Arthritis Consumer Experts' Biosimilars in Canada Webinar

Accessing care from anywhere | Arthritis TalksПодробнее

Arthritis At Home 195 – The implementation of the Ontario biosimilars transition policyПодробнее

Arthritis Research Education Series Ep. 11 Webinar - Biosimilars UnpackedПодробнее

Webinar: Subsequent Entry Biologics - Why these drugs should matter to youПодробнее

JointHealth™ Education - Biosimilar Transition Policy: What does it mean for IA patients?Подробнее

CADTH Webinar — Biologics and BiosimilarsПодробнее

Biosimilars Education Video Series 2: Transitioning between similar biologic medicationПодробнее

Biosimilars: What You Need to KnowПодробнее

Arthritis Consumer Experts' Biosimilars in Canada WebinarПодробнее

Understanding Biosimilars | Arthritis TalksПодробнее

Arthritis At Home Ep.95 – Learn more about ACE’s new and improved Biosimilars Exchange micrositeПодробнее

Arthritis At Home Ep.167 - Biosimilar Transition Policy: What does it mean for IA patients?Подробнее

Biosimilars Education Video Series 1: What are biosimilars?Подробнее

Interview 20 - Dr. Cathy Flanagan on the Biosimilars Initiative in British ColumbiaПодробнее

EyeSeeYou Vision Health Webinar | Biosimilars: International Policies and Professional PerspectivesПодробнее

Ep.171-New online course: Foundations of Originator & Biosimilar Biologics for Patients & CaregiversПодробнее

WEBINAR: Biologics & BiosimilarsПодробнее

Arthritis Biologics, Biosimilars, and JAK Inhibitors | Arthritis TalksПодробнее

Biosimilars Education Video Series 3: The societal benefits of biosimilarsПодробнее

Dr. Diane Lacaille - Biologics and Biosimilars: Are they equally effective and safe?Подробнее

Interview 34 – Dr. Diane Lacaille on biosimilars efficacy and personalizing care in arthritisПодробнее